AMERICAN BATTERY TECHNOLOGY Co: Form 10-Q for the period ended Mar 31, 2026
Filed with the SEC on May 11, 2026 and accepted by EDGAR at May 11, 2026, 12:46 ET.
Management's discussion and analysis
As filed, 28,589 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following discussion and analysis should be read in conjunction with our condensed consolidated financial statements and related notes in “Item 1. Condensed Consolidated Financial Statements”. References in this report to “American Battery,” the “Company,” “we,” “our” and “us” are references to American Battery Technology Company and its subsidiaries.
Forward-Looking Statements
We make forward-looking statements in this report and may make such statements in future filings with the Securities and Exchange Commission, or SEC. We may also make forward-looking statements in our press releases or other public or shareholder communications. Our forward-looking statements are subject to risks and uncertainties and include information about our current expectations and possible or assumed future results of our operations. When we use words such as “may,” “might,” “will,” “should,” “believe,” “expect,” “anticipate,” “estimate,” “continue,” “could,” “plan,” “potential,” “predict,” “forecast,” “project,” “intend,” “is focused on” or similar expressions, or make statements regarding our intent, belief, or current expectations, we are making forward-looking statements. Our forward-looking statements also include, without limitation, statements about our liquidity and capital resources; our ability to continue as a going concern; our ability to successfully execute on our business strategy; our ability to raise additional capital and statements regarding our anticipated future financial condition, operating results, cash flows and business plans.
While we believe our forward-looking statements are reasonable, you should not place undue reliance on any such forward-looking statements, which are based on information available to us on the date of this report or, if made elsewhere, as of the date made. Because these forward-looking statements are based on estimates and assumptions that are subject to significant business, economic and competitive uncertainties, many of which are beyond our control or are subject to change, actual results could be materially different. Factors that might cause such a difference include, without limitation, the risks and uncertainties discussed in this report, “Item 1A — Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025, and from time to time in our other reports filed with the SEC.
Other factors not currently anticipated may also materially and adversely affect our results of operations, cash flows, and financial position. There can be no assurance future results will meet expectations. Forward-looking statements speak only as of the date of this report and we expressly disclaim any intent to update or alter any statements whether as a result of new information, future events or otherwise, except as may be required by applicable law.
Overview
American Battery Technology Company (the “Company”) is a growth-stage company in the lithium–ion battery industry that is working to increase the domestic U.S. production of battery materials, such as lithium, nickel, cobalt, and manganese through its: (i) exploration of new, United States based primary resources of battery materials, (ii) development and commercialization of new technologies for the extraction of these battery materials from primary resources, and (iii) commercialization of an internally developed integrated process for the recycling of lithium–ion batteries. Through this three–pronged approach the Company is working to both increase the domestic production of these battery materials, and to ensure spent batteries have their elemental battery metals returned to the domestic manufacturing supply chain in an economical, environmentally-conscious, closed–loop fashion.
To implement this business strategy, the Company has constructed and is operating its first integrated lithium–ion battery recycling facility, which takes in waste and end–of–life battery materials from the electric vehicle, battery energy storage system (“BESS”), and consumer electronics industries. The ramp-up and operation of this facility remain top priorities, and the Company has significantly expanded resources to support its development. These efforts include hiring additional technical staff, expanding laboratory facilities, and purchasing equipment. As a result, the Company generated its first revenue in the fourth quarter of fiscal year 2024 and has achieved continued growth in production volumes and revenue through March 31, 2026.
The Company was awarded and has completed a competitively bid grant from the U.S. Advanced Battery Consortium to support a $2 million project to accelerate the development and demonstration of the technologies within this integrated lithium–ion battery recycling facility.
The Company has also been awarded an additional grant from the DOE to support a $20 million project under the Bipartisan Infrastructure Law to validate, test, and deploy three next-generation disruptive advanced separation and processing recycling technologies.
On March 28, 2024, the Company was selected for an approximately $19.5 million tax credit through the Qualifying Advanced Energy Project Credits program (the “48C program”). This tax credit was granted by the U.S. Department of Treasury Internal Revenue Service following a competitive technical and economic review process performed by the DOE, which evaluated the feasibility of applicant facilities to advance America’s buildout of globally competitive critical material recycling, processing, and refining infrastructure. This $19.5 million tax credit can be utilized both for the reimbursement of capital expenditures spent to date, and also for equipment and infrastructure for additional value-add operations at the Company’s battery recycling facility in the Tahoe-Reno Industrial Center (“TRIC”) near Reno, Nevada. As of March 31, 2026, the Company has incurred qualifying expenditures for this tax credit but will not recognize any amounts until it has reasonable assurance of compliance with the relevant standards.
Also on March 28, 2024, the Company was selected for an additional $40.5 million tax credit through the 48C program to support the design and construction of a new, next-generation, commercial battery recycling facility to be located in the United States. This award was granted by the U.S. Department of Treasury Internal Revenue Service following a competitive technical and economic review process performed by the DOE, which evaluated the feasibility of applicant facilities to advance America’s buildout of globally competitive critical material recycling, processing, and refining infrastructure. As of March 31, 2026, the Company has not incurred any qualifying expenditures towards this tax credit.
Additionally, the Company is accelerating the demonstration and commercialization of its internally developed low–cost and low–environmental impact processing train for the manufacturing of battery grade lithium hydroxide from Nevada–based sedimentary claystone resources. The Company was awarded and has completed a grant cooperative agreement from the DOE’s Advanced Manufacturing and Materials Technologies Office through the Critical Materials Innovation program to support a $4.5 million project for the construction and operation of a multi–ton per day integrated continuous demonstration system to support the scale–up and commercialization of these technologies. The Company has completed the construction and commissioning of this demonstration system, which enables the Company to demonstrate its technologies for accessing the lithium housed in its unconventional resource, TFLP, and to generate large amounts of battery grade lithium hydroxide for delivery to customers for qualifications and evaluation.
The TFLP is one of the largest identified lithium resources in the United States, and the Company recently published a Pre-Feasibility Study (“PFS”) that details inferred, indicated, and measured resources and proven and probable reserves at this property, as well as the technical and financial roadmap for bringing the associated lithium mine and lithium hydroxide monohydrate (“LHM”) refinery to commercialization. This PFS has estimated that the TFLP contains approximately 21.3 million tonnes LHM resource, with 2.7 million tonnes of LHM further classified as proven and probable reserves. The total processing costs for manufacturing this battery grade LHM is projected to be $4,307 per tonne LHM. Inferred, indicated, and measured resources have lower levels of geological confidence than proven and probable reserves, and in certain cases may not be considered when assessing the economic viability of a mining project.
In June 2025, the TFLP was selected by the National Energy Dominance Council and the FAST-41 Permitting Council as a Transparency Priority Project. This designation highlights the project’s role in advancing domestic critical mineral lithium production and supporting U.S. energy independence. In August 2025, the TFLP was further approved by the FAST-41 Permitting Council as a Covered Priority Project, which provided additional resources to streamlining the permitting efforts for this project.
Company Financial Highlights:
- The Company had cash and cash equivalents of $38.5 million as of March 31, 2026, of which $37.7 million was unrestricted. This was a $30.2 million increase in unrestricted cash from June 30, 2025.
- The Company held zero debt as of March 31, 2026, compared to $7.7 million as of March 31, 2025.
Fiscal Third Quarter 2026 Financial Highlights (Three Months):
- Revenue was $7.8 million for the three months ended March 31, 2026, as compared to $1.0 million for the three months ended March 31, 2025.
- Total cost of goods sold was $7.1 million for three months ended March 31, 2026, compared to $3.7 million for the three months ended March 31, 2025. Cost of goods sold for the three months ended March 31, 2026 included non-cash items, including depreciation of $1.0 million and stock-based compensation of $0.3 million. Excluding these non-cash items, cash cost of goods sold (a non-GAAP measure) for the three months ended March 31, 2026 was $5.8 million.
23
A reconciliation of cost of goods sold to cash cost of goods sold and adjusted gross margin
(both are a non-GAAP measure) for the three months ended March 31, 2026 was as follows:
| Description | Amount ($M) |
|---|---|
| Revenue | 7.8 |
| Cost of Goods Sold (GAAP) | 7.1 |
| Gross Margin | 0.7 |
| Description | Amount ($M) |
|---|---|
| Revenue | 7.8 |
| Cost of Goods Sold (GAAP) | 7.1 |
| Less: Depreciation Expense | (1.0) |
| Less: Stock-Based Compensation | (0.3) |
| Cash Cost of Goods Sold (Non-GAAP) | 5.8 |
| Adjusted Gross Margin | 2.0 |
- The Company has achieved a critical milestone this quarter, with the achievement of its first positive gross profit on revenue of $0.7 million.
- Excluding non-cash items, such as stock-based compensation and depreciation, the Company achieved an adjusted gross profit (a non-GAAP measure) of $2.0 million.
Management uses certain non-GAAP metrics to evaluate our operating and financial results. We believe the presentation of non-GAAP results is useful to investors for analysing business trends as well as to view the results from management’s perspective. Non-GAAP cost of goods sold excludes certain non-cash charges including depreciation expense and stock-based compensation. Non-GAAP results have limitations as an analytical tool, and you should not consider them in isolation or as a substitute for our results reported under GAAP.
Fiscal Year to Date 2026 Financial Highlights (Nine Months):
- Revenue was $13.5 million for the nine months ended March 31, 2026, as compared to $1.5 million for the nine months ended March 31, 2025.
- Total cost of goods sold was $17.9 million for nine months ended March 31, 2026, compared to $9.5 million for the nine months ended March 31, 2025. Cost of goods sold for the nine months ended March 31, 2026 included non-cash items, including depreciation of $3.0 million and stock-based compensation of $0.9 million. Excluding these non-cash items, cash cost of goods sold (a non-GAAP measure) for the nine months ended March 31, 2026 was $14.0 million.
A reconciliation of cost of goods sold to cash cost of goods sold and adjusted gross margin
(both are a non-GAAP measure) for the nine months ended March 31, 2026 was as follows:
| Description | Amount ($M) |
|---|---|
| Revenue | 13.5 |
| Cost of Goods Sold (GAAP) | 17.9 |
| Gross Margin | (4.4) |
| Description | Amount ($M) |
|---|---|
| Revenue | 13.5 |
| Cost of Goods Sold (GAAP) | 17.9 |
| Less: Depreciation Expense | (3.0) |
| Less: Stock-Based Compensation | (0.9) |
| Cash Cost of Goods Sold (Non-GAAP) | 14.0 |
| Adjusted Gross Margin | (0.5) |
Management uses certain non-GAAP metrics to evaluate our operating and financial results. We believe the presentation of non-GAAP results is useful to investors for analysing business trends as well as to view the results from management’s perspective. Non-GAAP cost of goods sold excludes certain non-cash charges including depreciation expense and stock-based compensation. Non-GAAP results have limitations as an analytical tool, and you should not consider them in isolation or as a substitute for our results reported under GAAP.
Components of Statements of Operations
The following table sets forth the Company’s operating results for the periods indicated:
| Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 | $ Change | % Change | Nine Months Ended March 31, 2026 | Nine Months Ended March 31, 2025 | $ Change | % Change | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7,811,229 | $979,977 | $6,831,252 | 697% | $13,508,649 | $1,514,377 | $11,994,272 | 792% |
| Cost of goods sold | 7,073,480 | 3,669,937 | 3,403,543 | 93 | 17,886,919 | 9,518,321 | 8,368,598 | 88 |
| Gross profit (loss) | 737,749 | (2,689,960) | 3,427,709 | (127) | (4,378,270) | (8,003,944) | 3,625,674 | (45) |
| Operating expense | ||||||||
| General and administrative | 29,841,644 | 3,665,608 | 26,176,036 | 714 | 37,379,145 | 16,348,471 | 21,030,674 | 129 |
| Research and development | 4,644,759 | 3,252,929 | 1,391,830 | 43 | 11,160,033 | 8,204,929 | 2,955,104 | 36 |
| Exploration | 657,021 | 1,036,584 | (379,563) | (37) | 1,496,072 | 1,691,659 | (195,587) | (12) |
| Total operating expenses | 35,143,424 | 7,955,121 | 27,188,303 | 342 | 50,035,250 | 26,245,059 | 23,790,191 | 91 |
| Other income (expense) | 569,478 | (850,866) | 1,420,344 | (167) | 996,785 | (2,342,019) | 3,338,804 | (143) |
| Net loss | (33,836,197) | (11,495,947) | (22,340,250) | 194 | (53,416,735) | (36,591,022) | (16,825,713) | 46 |
Results of Operations for the Three Months Ended March 31, 2026 and 2025
Revenue
During the three months ended March 31, 2026 and 2025, our revenue was $7.8 million and $1.0 million, respectively, which related to the sale of our products and byproducts resulting from recycling operations. The increase in revenue was primarily driven by an increase in processed feedstock, which enabled higher production throughput, as well as higher market prices for black mass and mixed metals byproducts during the current-year period.
Cost of Goods Sold
Cost of goods sold during the three months ended March 31, 2026 and 2025 were $7.1 million and $3.7 million, respectively. The increase in the current year was primarily driven by an increase of $0.5 million in higher headcount, as we hired to support expanded production capacity, an increase in facility absorption costs of $2.0 million as production volume increased, and an increase in feedstock costs of $0.9 million.
Operating Expenses
The Company incurred negative cash flows from operating activities of $2.7 million for the three months ended March 31, 2026 and $10.3 million for three months ended March 31, 2025.
During the three months ended March 31, 2026, the Company incurred $35.1 million of operating expenses compared to $8.0 million of operating expenses during the three months ended March 31, 2025. The increase is primarily due to the items described below:
General and administrative expenses consist of stock-based compensation, office expenses, legal, accounting, recruiting, business development, public relations, and general facility expenses. For the three months ended March 31, 2026, general and administrative expenses were $29.8 million, an increase of $26.2 million from the same period in the prior year. A majority of the increase is related to approximately $24.5 million of stock compensation expense associated with the fiscal year 2026 executive performance-based awards recognized in the current quarter upon finalization and approval of the performance milestones by the Board of Directors in January 2026. The expense recognized in the period was further impacted by the vesting of awards effective as of July 1, 2024, as well as a higher grant-date stock price for fiscal year 2026 awards compared to the prior year.
Research and development expenses consist primarily of personnel, laboratory leases, and supplies. Research and development expenses for the three months ended March 31, 2026 and 2025, were $4.6 million and $3.3 million, respectively. The increase is primarily related to an increase in stock compensation expense and payroll for $1.4 million as the Company hired additional engineers and technical program managers to support the operations of the Plant and the progression of the TFLP through the feasibility studies and National Environmental Policy Act (“NEPA”) review processes.
Exploration costs consist primarily of drilling, assay, claim fees, personnel, stock-based compensation, office and warehouse, travel, and other costs related to exploration of claims in central Nevada. Exploration expenses totaled $0.7 million for the three months ended March 31, 2026 and $1.0 million for the three months ended March 31, 2025 respectively.
Other Income (Expense)
Other income was $0.6 million in the three months ended March 31, 2026, versus other expense of $0.9 million during the same period in the prior year. The change for the three months ended March 31, 2026 primarily resulted from a $0.9 million decrease in the amortization and accretion of financing costs, an increase in interest income of $0.3 million due to investment of cash in money market funds, and an increase in other income of $0.2 million.
Results of Operations for the Nine Months Ended March 31, 2026 and 2025
Revenue
During the nine months ended March 31, 2026 and 2025, our revenue was $13.5 million and $1.5 million, respectively, which related to the sale of our products and byproducts resulting from recycling operations. The increase in revenue was primarily driven by an increase in processed feedstock, which enabled higher production throughput, as well as higher market prices for black mass and mixed metals byproducts during the current-year period.
Cost of Goods Sold
Cost of goods sold during the nine months ended March 31, 2026 and 2025 were $17.9 million and $9.5 million, respectively. The increase in cost of sales was primarily driven by an increase of $3.7 million in higher headcount, as we hired to support expanded production capacity, an increase in facility absorption costs of $2.6 million as production volume increased, and an increase in feedstock costs of $2.2 million.
Management uses certain non-GAAP metrics to evaluate our operating and financial results. We believe the presentation of non-GAAP results is useful to investors for analysing business trends as well as to view the results from management’s perspective. Non-GAAP cost of goods sold excludes certain non-cash charges including depreciation expense and stock-based compensation. Non-GAAP results have limitations as an analytical tool, and you should not consider them in isolation or as a substitute for our results reported under GAAP.
Operating Expenses
The Company incurred negative cash flows from operating activities of $19.6 million for the nine months ended March 31, 2026 and $23.1 million for nine months ended March 31, 2025.
During the nine months ended March 31, 2026, the Company incurred $50.0 million of total operating expenses compared to $26.2 million of total operating expenses during the nine months ended March 31, 2025. The increase is primarily due to the items described below:
General and administrative expenses consist of stock-based compensation, office expenses, legal, accounting, recruiting, business development, public relations, and general facility expenses. For the nine months ended March 31, 2026, general and administrative expenses were $37.4 million, an increase of $21.0 million compared to the same period in the prior year, primarily driven by stock-based compensation expense of $24.5 million associated with the fiscal year 2026 executive performance-based awards recognized in the current quarter upon finalization and approval of the performance milestones by the Board of Directors in January 2026. The expense recognized in the period was further impacted by the vesting of awards effective as of July 1, 2024, as well as a higher grant-date stock price for fiscal year 2026 awards compared to the prior year
Research and development expenses consist primarily of personnel, laboratory leases, and supplies. Research and development expenses for the nine months ended March 31, 2026 and 2025, were $11.2 million and $8.2 million, respectively. The increase was primarily driven by higher payroll costs of $0.8 million related to expansion of engineering and technical teams to support production ramp-up, increased stock-based compensation of $1.7 million from new hires and fiscal year 2026 performance awards, and increased depreciation expense of $0.5 million.
Exploration costs consist primarily of drilling, assay, claim fees, personnel, stock-based compensation, office and warehouse, travel, and other costs related to exploration of claims in central Nevada. Exploration expenses remained somewhat consistent year-over-year totaling $1.5 million for the nine months ended March 31, 2026, compared to $1.7 million during the same period in the prior year.
Other Income (Expense)
Other income was $1.0 million in the nine months ended March 31, 2026, versus other expense of $2.3 million during the same period in the prior year. The change for the nine months ended March 31, 2026 primarily resulted from a change in fair value of the derivative liability of $0.7 million (see Note 13 of the condensed consolidated financial statements for further detail), $0.7 loss on debt extinguishment, $0.6 million loss on private placement, $0.9 million for change in fair value of liability classified instruments, an increase in interest income due to investment of cash in money market funds of $0.7 million, an increase in other income of $0.5 million, and a decrease in the amortization and accretion of financing costs of $2.5 million.
Liquidity and Capital Resources
At March 31, 2026, the Company had available cash of $37.7 million and total assets of $119.4 million compared to available cash of $7.5 million and total assets of $84.5 million at June 30, 2025. The increase of cash is due to the raising of capital through the exercising of warrant agreements, utilization of the ATM sales agreement with Virtu Americas, LLC, and revenue from sales of its products.
The Company had total current liabilities of $6.6 million at March 31, 2026, compared to $13.7 million at June 30, 2025. The decrease related to conversion of the debt as discussed in Note 11 and timing of payments for accounts payable and accrued expenses.
As of March 31, 2026, the Company had working capital of $46.0 million compared to $10.9 million at June 30, 2025.
Cash Flows
For the nine months ended March 31:
| March 31, 2026 | March 31, 2025 | |
|---|---|---|
| Cash Flows used in Operating Activities | $(19,616,904) | $(23,099,351) |
| Cash Flows used in Investing Activities | (9,726,151) | (2,000,713) |
| Cash Flows provided by Financing Activities | 55,353,778 | 25,947,535 |
| Net Increase in Cash and Restricted Cash During the Period | 26,010,723 | 847,471 |
Cash from Operating Activities
During the nine months ended March 31, 2026, the Company used $19.6 million of cash for operating activities, compared to $23.1 million during the nine months ended March 31, 2025. In both periods, the cash used supported an increased scale of operations including increased employee headcount and personnel costs, increased production, and increased administrative costs.
Cash from Investing Activities
During the nine months ended March 31, 2026, the Company used cash in investing activities of $9.7 million. The Company used $8.4 million for acquisition of property and equipment for its recycling facilities while $1.3 million was used for capitalization of costs related to proven and probable reserves. This is in comparison to cash used in investing activities of $2.0 million for the nine months ended March 31, 2025 for acquisition of property and equipment.
Cash from Financing Activities
During the nine months ended March 31, 2026, the Company had cash provided by financing activities of $55.4 million, compared to $25.9 million provided during the nine months ended March 31, 2025. The Company has relied on equity and debt financing to support its increased operating activities, the ramp up of the recycling plant, development of the lithium claystone pilot plant, and upgrades to the geological classification of its Tonopah Flats claims through additional studies and assessments.
The Company received proceeds of $55.4 million from equity financings and warrant conversions during the nine months ended March 31, 2026, compared to $33.4 million in the prior year period. In the nine months ended March 31, 2025, equity financing proceeds were offset by the repayment of $7.5 million of notes payable. In the current period, the carrying value of notes payable totaling $8.0 million was fully extinguished through conversion to equity, and no amounts remain outstanding.
Working Capital
| March 31, 2026 | June 30, 2025 | |
|---|---|---|
| Current Assets | $53,415,858 | $29,532,110 |
| Restricted Cash | (800,000) | (5,000,000) |
| Current Liabilities | 6,580,188 | 13,668,605 |
| Working Capital | 46,035,670 | 10,863,505 |
Future Financing
The Company will continue to rely on sales of our common shares, debt, or other financing to fund our business operations as needed beyond any revenue generated from internal operations and the government tax credits and grants we have been awarded. Issuances of additional shares will result in dilution to existing stockholders. There is no assurance that we will achieve any additional sales of the securities or arrange for debt or other financing to fund planned operating activities, acquisitions, and exploration activities.
Critical Accounting Estimates
Our condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. We evaluate our estimates and assumptions on an ongoing basis using historical experience and other factors and adjust those estimates and assumptions when facts and circumstances dictate. Actual results could differ materially from those estimates and assumptions.
While some of our significant accounting policies are more fully described in Note 3, “Summary of Significant Accounting Policies,” in the notes to our condensed consolidated financial statements in this Quarterly Report on Form 10-Q, all our critical accounting policies and significant estimates are detailed in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025.
Off-Balance Sheet Arrangements
As of March 31, 2026, we had no off-balance sheet arrangements.
Controls and procedures
As filed, 7,203 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Controls and Procedures
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act of 1934, as amended (the “Exchange Act”). Disclosure controls and procedures are controls and other procedures designed to ensure that the information required to be disclosed by us in the reports that we file or submit under the Exchange Act (15 U.S.C. 78a et seq.) is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and our principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable and not absolute assurance of achieving the desired control objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
The Company’s management, with the participation of the Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of March 31, 2026, the end of the period covered by this report. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of March 31, 2026, the Company’s disclosure controls and procedures are not effective, based on the material weaknesses described below.
Management’s Report on Internal Control over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act). Management, with the participation of the principal executive officer and principal financial officer, under the oversight of our Board of Directors, assessed the effectiveness of our internal control over financial reporting as of March 31, 2026, based on the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework (2013 Framework). Based on this assessment, management concluded that, as of March 31, 2026, our internal control over financial reporting was not effective, due to the material weaknesses in internal control over financial reporting, described below.
Internal control over financial reporting is a process designed under the supervision and with the participation of our management, including the individuals serving as our principal executive officer and principal financial officer, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America.
A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of annual or interim financial statements will not be prevented or detected on a timely basis.
Material Weakness in Internal Control over Financial Reporting
The Company did not maintain a sufficient complement of personnel with the appropriate level of technical accounting expertise to effectively identify, evaluate, and design controls related to complex transactions. Additionally, the Company did not maintain adequate segregation of duties within its financial reporting processes, resulting in incompatible responsibilities and insufficient independent review controls. As a consequence, internal control deficiencies related to the design and operation of process-level controls were determined to be pervasive throughout the Company’s financial reporting processes. These material weaknesses create a reasonable possibility that a material misstatement of account balances or disclosures in the consolidated financial statements may not be prevented or detected in a timely manner. Therefore, we concluded that the deficiencies represent material weaknesses in the Company’s internal control over financial reporting and our internal control over financial reporting was not effective as of March 31, 2026.
Remediation Plan
Remediation Efforts for Identified Material Weaknesses
We have implemented, and are continuing to design and implement, measures to remediate the control deficiency that resulted in the material weaknesses identified in our internal control over financial reporting.
Remediation Measures in Progress:
- We are designing and implementing controls related to our internal control risk assessment process, including the identification and response to relevant risks.
- We are designing and implementing general information technology (IT) controls, including logical access and program change controls, and are in the process of hiring qualified IT personnel.
- We are designing and implementing controls over the evaluation and oversight of relevant service organizations.
- We have engaged a third-party consultant that is assisting management in the evaluation, design and implementation of internal controls over financial reporting.
- We will hire additional personnel with appropriate level of technical accounting expertise to effectively identify, evaluate and design controls related to complex transactions.
- On January 25, 2026, the Board of Directors of the Company appointed Alejandro Flores Arteaga to serve as Chief Financial Officer of the Company, effective February 9, 2026. Jesse Deutsch, the Interim Chief Financial Officer, retired from the Company effective February 9, 2026.
We will consider the material weaknesses remediated when the relevant controls have been fully implemented, have operated for a sufficient period of time, and when management has concluded, through testing, that these controls are operating effectively. We expect to remediate the material weaknesses by the end of fiscal year 2027. As we continue to monitor and evaluate the effectiveness of our internal control over financial reporting, we may implement additional changes or enhancements as deemed necessary.
Changes in Internal Control over Financial Reporting
Except with respect to the changes in connection with the implementation of the initiatives to remediate the material weaknesses noted above, there were no changes in the Company’s internal control over financial reporting that occurred during the three months ended March 31, 2026 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
Risk factors
As filed, 340 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Our business is subject to various risks, including those described in Part I, Item 1A “Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended June 30, 2025. There have been no changes to the risk factors set forth in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025, under “Item 1A - Risk Factors”.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2026-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2026-01-01 to 2026-03-31 | $7.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2025-07-01 to 2026-03-31 | $13.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2026-01-01 to 2026-03-31 | $7.1m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2025-07-01 to 2026-03-31 | $17.9m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2026-01-01 to 2026-03-31 | $737.7k | us-gaap:GrossProfit |
| Gross profit | 9 months2025-07-01 to 2026-03-31 | −$4.4m | us-gaap:GrossProfit |
| Research and development | 3 months2026-01-01 to 2026-03-31 | $4.6m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2025-07-01 to 2026-03-31 | $11.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2026-01-01 to 2026-03-31 | −$34.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2025-07-01 to 2026-03-31 | −$54.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2026-01-01 to 2026-03-31 | −$335.7k | us-gaap:InterestExpenseNonoperating |
| Interest expense | 9 months2025-07-01 to 2026-03-31 | −$641.4k | us-gaap:InterestExpenseNonoperating |
| Net income | 3 months2026-01-01 to 2026-03-31 | −$33.8m | us-gaap:NetIncomeLoss |
| Net income | 9 months2025-07-01 to 2026-03-31 | −$53.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2026-01-01 to 2026-03-31 | −$0.26 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2025-07-01 to 2026-03-31 | −$0.43 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2026-01-01 to 2026-03-31 | −$0.26 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2025-07-01 to 2026-03-31 | −$0.43 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2026-01-01 to 2026-03-31 | 131,855,794 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2025-07-01 to 2026-03-31 | 124,415,975 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2026-01-01 to 2026-03-31 | −$2.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Operating cash flow | 9 months2025-07-01 to 2026-03-31 | −$19.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2026-03-31 | $37.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2026-03-31 | $53.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2026-03-31 | $119.4m | us-gaap:Assets |
| Current liabilities | At period end2026-03-31 | $6.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2026-03-31 | $6.7m | us-gaap:Liabilities |
| Shareholders' equity | At period end2026-03-31 | $112.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001493152-26-022149. Last ingested by Listed: Oct 24, 2026, 15:13 ET. Listed shows no prices and gives no investment advice.